XIAP and cancer: This is especially true for cancer cells with defective mitochondrial death signaling: repression of XIAP mRNA by RNAi or the specific XIAP-transcription-inhibitory compound Mithramycin A (59) overcomes TRAIL-resistance in carcinoma cells that show deregulation of the intrinsic apoptosis signaling pathway (60).